Bayer, McNeil St. Joseph Aspirin Ad Dispute Moves To Federal Court
This article was originally published in The Tan Sheet
Executive Summary
A recent British Medical Journal study does not support McNeil Consumer & Specialty Pharmaceuticals' advertising claims that 81 mg aspirin "is just as effective as 325 mg in reducing the risk of recurrent heart attacks," Bayer says in a lawsuit filed in New York federal court April 25